Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1256 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1256 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0043 | 0.1256 | 0.5 |
Brugia malayi | beta-lactamase | 0.0043 | 0.1256 | 0.2505 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.5014 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.1256 | 0.2505 |
Onchocerca volvulus | 0.0043 | 0.1256 | 0.5 | |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.1256 | 0.5 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0.1256 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.1256 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.1256 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.1256 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.1256 | 0.2505 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.1256 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0043 | 0.1256 | 0.2505 |
Onchocerca volvulus | 0.0043 | 0.1256 | 0.5 | |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.1256 | 0.2505 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.1256 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Onchocerca volvulus | 0.0043 | 0.1256 | 0.5 | |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0.1256 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.1256 | 1 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.1256 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0043 | 0.1256 | 0.2505 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.1256 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.5014 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.1256 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1256 | 0.2505 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.1256 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.1256 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.5014 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.1256 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.